BPC-157 + TB500 Blend (Wolverine Stack) – 10MG

Wolverine Stack (BPC-157 + TB-500): Benefits & Overview

The Wolverine Stack — BPC-157 + TB-500 — is the most popular dual-peptide repair blend available in Canada. Combining BPC-157 (10 mg vial, 5 mg each) with TB-500 in a single lyophilized vial, this stack pairs two of the most extensively studied regenerative peptides: BPC-157 drives nitric oxide signalling and growth factor upregulation for local tissue repair, while TB-500 contributes systemic actin modulation and anti-inflammatory signalling for full-body recovery.

BPC-157 drives nitric oxide signalling and growth factor (VEGF, EGF) upregulation for angiogenesis and local tissue repair. TB-500 contributes systemic actin modulation, ILK activation, and anti-inflammatory signalling. Together, their effects on tendon, ligament, muscle, gut, and cardiovascular tissue regeneration exceed what either peptide achieves alone.

BPC-157 + TB-500 Benefits & Uses

• Synergistic tendon, ligament, and muscle tissue regeneration
• Multi-mechanism wound healing (NO pathway + actin pathway)
• Anti-inflammatory and pro-repair microenvironment studies
• Gastrointestinal mucosal repair (BPC-157 component)
• Cardiac protection and post-ischaemic repair models (TB-500 component)
• Joint and connective tissue recovery research

How the Wolverine Stack Works

BPC-157 upregulates NO synthase, VEGF, and EGF receptors, promoting angiogenesis, fibroblast migration, and growth factor signalling at injury sites. It also stabilises the gut-brain axis and protects GI mucosa. TB-500 sequesters G-actin to shift the G/F-actin equilibrium toward cellular migration, activates ILK for ECM remodelling, and systemically delivers anti-inflammatory and pro-angiogenic signals via VEGF upregulation. The combination creates a broad, complementary repair environment targeting both the structural and vascular components of tissue healing.

BPC-157 + TB-500 10mg Vial Specifications

• Contents: BPC-157 (5 mg) + TB-500 (5 mg) — 10 mg total
• Purity: ≥98% each component (third-party HPLC verified)
• Form: Lyophilized powder (co-lyophilized blend)
• Storage: −20 °C (long-term); 4 °C (short-term)
• Reconstitution: Bacteriostatic water

BPC-157 + TB-500 Canada FAQs

Why are BPC-157 and TB-500 studied together?

BPC-157 targets local repair via NO and growth factor signalling; TB-500 acts systemically via actin modulation and angiogenesis. Their mechanisms don’t overlap — they address different layers of the healing cascade. Combining them in preclinical models typically produces superior tissue repair outcomes compared to either peptide alone.

What is the ratio of BPC-157 to TB-500 in the Wolverine Stack?

The Wolverine Stack contains 5 mg BPC-157 and 5 mg TB-500 per 10 mg vial — a 1:1 ratio, the most common protocol used in preclinical combination research.

Is the Wolverine Stack available in Canada?

Reconstitution & Dosing Guide

How to Reconstitute

Add 3.0 mL of bacteriostatic water to the vial. Inject the water slowly down the inside wall of the vial — do not inject directly onto the powder. Gently swirl until fully dissolved; do not shake. This yields approximately 3.33 mg/mL total blend. Store the reconstituted vial at 4 °C and use within 28 days.

Low Starting Dose

• Dose per injection: 600 mcg total (300 mcg BPC-157 + 300 mcg TB-500) — 18 units (0.18 mL) on a U-100 insulin syringe
• Frequency: Once daily, subcutaneous injection
• Cycle length: 8–12 weeks

Loading weeks 1–4: 600 mcg daily; maintenance weeks 5–12: 600 mcg daily.

Start at the lowest effective dose and adjust based on individual response. Consult a qualified healthcare professional before use.